Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Cellular Origins — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Cellular Origins and Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell and Gene Therapy Manufacturing

Oct 16, 2024•over 1 year ago

Contract Type

agreement

HertfordManufacturing

Description

Cellular Origins and Fresenius Kabi have signed a development agreement to integrate Fresenius Kabi’s suite of cell therapy processing technologies within Cellular Origins’ CGT robotic manufacturing platform Constellation™. The aim of this work is to assist cell therapy developers to manufacture their therapies at scale using their preferred processing tools.

Company Information

Company

Cellular Origins

Location

Hertford, Hertfordshire, United Kingdom

About

Cellular Origins, a TTP company, is focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies. Created to provide therapeutic developers access to the equipment they want, at the capacity they need, Cellular Origins’ proprietary technology addresses the challenges associated with manufacturing at scale, with an elegant solution for automated sterile fluidic interconnection that reduces cost and labour, eliminating human error, and increasing efficiency.

Predictive Intelligence
Strategic

ML-powered predictions for Cellular Origins's next move

Learn about Strategic plan

Related People

Suggested for you

Sign in to view contact details

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months